ASHLEY ROBINSON: Open Payments
NPI 1588207807 · VESTAVIA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,530 in 56 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $397 · 2025 $1,530
Food & beverage: $1,530
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 13 | $554 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $237 |
| Axsome Therapeutics, Inc. | 8 | $182 |
| Almatica Pharma LLC | 6 | $95 |
| Alkermes, Inc. | 3 | $71 |
| ABBVIE INC. | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Collegium Pharmaceutical, Inc. | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $40 |
Products named: HETLIOZ, FANAPT, CAPLYTA, Auvelity, LOREEV XR, VRAYLAR, REXULTI, Jornay PM.
Industry payments across AL — which companies pay providers there.
